
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Lombard Med.Tec | LSE:LMT | London | Ordinary Share | GB00B7FT8W85 | ORD 20P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 188.50 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
08/4/2013 14:06 | i meant the RNS for the results BMW30csl. as this will i hope bring us more details about the future direction of the company. | ![]() glasswala | |
08/4/2013 13:59 | What rns is out tomorrow? | ![]() bmw30csl | |
08/4/2013 10:27 | This looks like a very tight run ship. No leakage(news)has occurred with the RNS out tomorrow I would have expected a few games being played by the MM's today but looks like no one is the wiser or this share just has not reached the wider public's attention and is below the radar of most. Lets hope the news is what we have been waiting for and we get more institutions on board for long term growth. | ![]() glasswala | |
04/4/2013 11:48 | I think just about everyone on this BB is of the opinion that a takeover is inevitable - correct me if I'm wrong. The only thing left for us while we wait is to hold a sweepstake on the month of the inevitable takeover.The prize is an awesome silver trophy which the winner can download from this BB. | nod | |
03/4/2013 17:30 | Yes the reason I added, was the feeling something is worrying the mm's, they don't want give the market any ideas that someone is more than a little interested. | ![]() rayrac | |
03/4/2013 13:14 | Not all trades are showing, my add on buy for inst'. And still not showing, wonder where it went? Only 3k, but it's annoying. | ![]() rayrac | |
03/4/2013 12:36 | Stable According to the statement released in February of this year Japanese approval is now anticipated in 2014: "U.S. approval of Aorfix(TM) also triggers the Company's ability to draw down $2.5m from the $5.0m loan facility granted by its exclusive distribution partner in Japan, Medico's Hirata Inc. Medico's Hirata is a leading supplier and developer of medical device products in Japan, with the sales infrastructure to maximise the potential of Aorfix(TM) in this important market. Lombard Medical continues to work with its partner to achieve Aorfix(TM) approval in Japan, which it anticipates will be in 2014." | ![]() orange1 | |
03/4/2013 12:13 | slowly moving upwards now that only a few days to go for the next update...This will hopefully be good news to take it upwards further. | ![]() glasswala | |
31/3/2013 20:46 | Have I missed it or are we still awaiting Japanese approval? I was hoping for news following the usa . More money to come when this approval is forthcoming so may be more to hear next Tuesday week,when i will be away. | ![]() stable | |
28/3/2013 20:23 | I would not discount Medtronic as a buyer of LMT. They are well-placed to achieve the full potential of Aorfix within just a few years. If the numbers stack up another product in the portfolio may be beneficial. It expands their sales and prevents a competitor from acquiring Aorfix. As has been pointed out on this BB, the market for Aorfix could be larger than quoted if cases at the fringe choose Aorfix over other currently available products because Aorfix is seen as the more flexible choice and less expensive in the long-term. The other poster worded it much better than me. | nod | |
28/3/2013 11:53 | Nod-interesting article..... Where does that leave LMT especially as this type of procedures has no other FDA approved products only Open Surgery remains an option which i m led to believe carries higher risk and is a more costly procedure. Surely this will become of interest somewhile later on which will hopefully mean a higher share price by then and a even higher take out price assuming no hanky panky going on between the larger shareholders etc.. | ![]() glasswala | |
28/3/2013 03:04 | An interesting article in Seeking Alpha on Medtronic and its next possible acquisition. The analysis gives a good overview of the players. It recognises Aorfix as a niche product but largely disregards LMT as being too small. LMT has been small but that will surely change now Aorfix has FDA approval. http://seekingalpha. | nod | |
27/3/2013 02:52 | It's all about getting surgeons to adopt the product and a steady increase in patients and revenues.Just over a year ago the FDA approved another 50 patients in the USA. There were around 200 patients in the four main European markets. I presume these have gone well.We should get updated figures on 9 April. We would hope there has been pent up demand in the USA. | nod | |
26/3/2013 23:27 | Are these new names? Why the excitement? | ![]() bmw30csl | |
26/3/2013 13:27 | Does this look interesting, or does it? About Us Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sectors. We invest across all stages of company development including early and late-stage venture financing, growth equity and public companies. Founded in 1973, Abingworth has a lengthy track record of building market leading companies. Our specialist team of over 20 professionals has a broad range of skills, including scientific and business expertise as well as investment banking, recruitment and legal knowledge. These resources are made available to portfolio companies. Abingworth has funds under management of over $1.25 billion and offices in London, Menlo Park (California) and Boston. Venture Capital Growth Equity Public Markets Edwin Moses, Portfolio Company Chairman and former CEO of Oxford Asymmetry I am currently working with Abingworth in four of the companies in which they have invested. They are absolutely consistent in their enthusiastic and knowledgeable support and commitment. Most impressively, they have differentiated themselves dramatically from other investors by being able to provide their companies with in-house access to a wide variety of critical specialist expertise in the areas of entrepreneurial management, technical, legal, human resources, M&A and finance. Abingworth is far more than a provider of cash just looking for a return. It is a partner with integrity focused on growing genuine value in developing biotechnology companies. | ![]() rayrac | |
26/3/2013 12:36 | Above 11%--AGE Above 7%--ABV V Above 18%--Abingworth LLP | ![]() skinny | |
25/3/2013 17:09 | Ha Rayrac, I don't think turning the sofa upside down will help much. Busy averaging down on ptr! | ![]() bmw30csl | |
25/3/2013 16:00 | 3s6d, can we move on now? | ![]() philo124 | |
25/3/2013 13:26 | Why, you got some spare? | ![]() rayrac | |
25/3/2013 12:30 | How much more money does this company need to raise to get the show up and running? | ![]() bmw30csl | |
25/3/2013 08:27 | Flavio_Monteiro 20 Feb'13 - 09:57 - 1542 of 1594 0 0 edit Gap Up needs filling before rise up Guys .................... I tried to buy some of these on Thursday on the 'Gap Fill' but could not get an electronic price for a quantity of 5K Shares! These appear tightly held. Good luck to holders. Lombard Medical have a great future. | ![]() flavio_monteiro |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions